10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum  -lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre

• Published in: Journal of antimicrobial chemotherapy Vol. 68; no. 3; pp. 562 - 568
• Main Authors: Nicolas-Chanoine, M.-H., Gruson, C., Bialek-Davenet, S., Bertrand, X., Thomas-Jean, F., Bert, F., Moyat, M., Meiller, E., Marcon, E., Danchin, N., Noussair, L., Moreau, R., Leflon-Guibout, V.
• Format: Journal Article
• Language: English
• Published: Oxford Oxford Publishing Limited (England) 01.03.2013
• Subjects: Bacterial infections; beta -Lactamase; Digestive tract; E coli; Enzymes; Escherichia coli; Evolution; Feces; Inventories; Phylogenetics; Phylogeny; Polyclonal antibodies; Risk factors; Paris France

In 2006, 0.6% of healthy subjects living in the Paris area had extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in their gut. To assess the evolution of this rate, a study identical to that of 2006 was conducted in 2011. Healthy adults who visited the IPC check-up centre in February-M...